Bevacizumab-induced tumor vessel remodeling in rhabdomyosarcoma xenografts increases the effectiveness of adjuvant ionizing radiation
- 30 June 2010
- journal article
- research article
- Published by Elsevier BV in Journal of Pediatric Surgery
- Vol. 45 (6), 1080-1085
- https://doi.org/10.1016/j.jpedsurg.2010.02.068
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Pediatric Soft Tissue SarcomasSurgical Clinics of North America, 2008
- Bevacizumab-Induced Transient Remodeling of the Vasculature in Neuroblastoma Xenografts Results in Improved Delivery and Efficacy of Systemically Administered ChemotherapyClinical Cancer Research, 2007
- VEGF-targeted cancer therapy strategies: current progress, hurdles and future prospectsTrends in Molecular Medicine, 2007
- Analysis of Prognostic Factors in Patients With Nonmetastatic Rhabdomyosarcoma Treated on Intergroup Rhabdomyosarcoma Studies III and IV: The Children's Oncology GroupJournal of Clinical Oncology, 2006
- Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acidOncogene, 2005
- Enforced expression of tissue inhibitor of matrix metalloproteinase-3 affects functional capillary morphogenesis and inhibits tumor growth in a murine tumor modelBlood, 2002
- The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major Lessons From the IRS-I Through IRS-IV Studies as Background for the Current IRS-V Treatment ProtocolsSarcoma, 2001
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- A new glioma model in rat: The C6 spheroid implantation technique permeability and vascular characterizationJournal of Neuro-Oncology, 1987
- Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites FluidScience, 1983